mitoXANTRONE

Product NDC
71288-178
11-digit product format
712880178
Labeler code
71288
Product ID
71288-178_37d2fbfc-59e6-437f-90d2-cab7b7d099f1
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
mitoXANTRONE
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Labeler
Meitheal Pharmaceuticals Inc.
Application
ANDA077356
Marketing category
ANDA
Marketing start
2025-06-01
Substance
MITOXANTRONE HYDROCHLORIDE
Active strength
2 mg/mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
mitoXANTRONE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MITOXANTRONE HYDROCHLORIDE2 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiU6USW86RD0
Rxcui197989

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71288-178-10mitoXANTRONE1 in 1 CARTONINJECTION, SOLUTION, CONCENTRATE11
71288-178-10mitoXANTRONE10 mL in 1 VIAL, MULTI-DOSEINJECTION, SOLUTION, CONCENTRATE101

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71288-178-10ML - Milliliter71288-1789b12deb4-235e-459b-972b-69f9b9c2d5f412025-09-12

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
197989mitoXANTRONE 2 MG/ML Injectable SolutionPSN1634528a-30c5-4309-acc8-4c0293ae14ae1
197989mitoxantrone 2 MG/ML Injectable SolutionSCD1634528a-30c5-4309-acc8-4c0293ae14ae1
197989mitoxantrone (as mitoxantrone hydrochloride) 2 MG/ML Injectable SolutionSY1634528a-30c5-4309-acc8-4c0293ae14ae1
197989mitoxantrone 20 MG per 10 ML Injectable SolutionSY1634528a-30c5-4309-acc8-4c0293ae14ae1
197989mitoxantrone 25 MG per 12.5 ML Injectable SolutionSY1634528a-30c5-4309-acc8-4c0293ae14ae1
197989mitoxantrone 30 MG per 15 ML Injectable SolutionSY1634528a-30c5-4309-acc8-4c0293ae14ae1
197989mitoxantrone 45 MG per 22.5 ML Injectable SolutionSY1634528a-30c5-4309-acc8-4c0293ae14ae1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
71288-178-10712880178101 VIAL, MULTI-DOSE in 1 CARTON (71288-178-10) / 10 mL in 1 VIAL, MULTI-DOSE2025-06-01NoNoCurrent